These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9005295

  • 1. Treatment of non-insulin-dependent diabetes mellitus.
    Davidson MB.
    Mayo Clin Proc; 1997 Jan; 72(1):92. PubMed ID: 9005295
    [No Abstract] [Full Text] [Related]

  • 2. Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.
    Riddle MC.
    Diabetes Res Clin Pract; 1991 Jan; 11(1):3-8. PubMed ID: 2019232
    [No Abstract] [Full Text] [Related]

  • 3. [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
    Ohmura E, Hosaka D, Imai Y, Kawazu S.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():470-5. PubMed ID: 12387036
    [No Abstract] [Full Text] [Related]

  • 4. New insights into the older hypoglycemic agents in type 2 diabetes therapy.
    Cao M, Bloomgarden Z.
    J Diabetes; 2020 Nov; 12(11):844-847. PubMed ID: 32767624
    [No Abstract] [Full Text] [Related]

  • 5. Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor.
    Riddle MC.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S125-30. PubMed ID: 18227472
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients.
    Kiayias JA, Vlachou ED, Theodosopoulou E, Lakka-Papadodima E.
    Diabetes Care; 2002 Jul; 25(7):1251-2. PubMed ID: 12087036
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical experience with exenatide in a routine secondary care diabetes clinic.
    Natarajan B, Edavalath M, Davies J, Jenkins L, Marshall-Richards N, Evans D, Price DE, Bain SC, Stephens JW.
    Prim Care Diabetes; 2010 Apr; 4(1):57-60. PubMed ID: 20022310
    [Abstract] [Full Text] [Related]

  • 12. A summary of the ADVANCE Trial.
    Heller SR, ADVANCE Collaborative Group.
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S357-61. PubMed ID: 19875581
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Are you up-to-date on diabetes medications?
    Scemons D.
    Nursing; 2007 Jul; 37(7):45-9; quiz 49-50. PubMed ID: 17603373
    [Abstract] [Full Text] [Related]

  • 15. Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent.
    Osei K, Falko JM.
    Am J Med Sci; 1985 Apr; 289(4):148-53. PubMed ID: 3920907
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.
    Dills DG, Schneider J.
    Horm Metab Res; 1996 Sep; 28(9):426-9. PubMed ID: 8911977
    [Abstract] [Full Text] [Related]

  • 17. Investigation of the introduction of three times daily injections of Insulin Lispro Mixture-50 on an outpatient basis: therapeutic effects of 12 months' treatment with and without concomitant sulfonylurea.
    Suzuki K, Morikawa H, Iwanaga M, Aizawa Y.
    J Diabetes; 2012 Sep; 4(3):262-3. PubMed ID: 22325575
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Insulin secretagogues: who, what, when, and how?
    Dailey G.
    Curr Diab Rep; 2005 Oct; 5(5):329-32. PubMed ID: 16188166
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.